Clinical observation, presented conservatively
This page summarizes real-world clinical observations, selected case documentation, and published foundations that inform Meibum Scientific’s biofilm-centric disease model. The intent is to provide context without overstating conclusions.
Clinical case observations
Clinical case observations demonstrate measurable patterns of change following protocolized intervention, including reduced lid inflammation, improved gland expressibility, and symptom improvement. These observations have been noted across multiple patient profiles and treatment settings.
- Lid margin appearance and inflammatory features
- Meibum expressibility and qualitative changes
- Patient-reported symptom trajectories
Observations are reported as real-world clinical patterns. They should not be interpreted as generalized outcomes.
Published foundations
Peer-reviewed publications and white papers provide scientific context for the biofilm-driven disease model and inform ongoing protocol development. These materials support the mechanistic framework without implying uniform clinical outcomes.
Background literature relevant to surface biofilm biology, inflammation, and gland dysfunction mechanisms.
Materials that describe sequencing logic and clinical implementation principles.
Updates are informed by clinical feedback loops and evolving scientific understanding.
Request supporting materials
If you are evaluating implementation, we can provide additional background, education materials, and protocol context.
For clinician and partner inquiries.